Published in Aliment Pharmacol Ther on June 20, 2013
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol (2014) 3.38
Estimating causal effects from large data sets using propensity scores. Ann Intern Med (1997) 19.65
Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol (1993) 13.16
Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology (2010) 8.11
Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31
Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology (2010) 3.00
Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis. J Hepatol (2012) 2.93
Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol (2000) 2.55
Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis (2008) 2.47
Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol (2009) 2.42
Severe sepsis in cirrhosis. Hepatology (2009) 2.33
Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective. Am J Gastroenterol (2009) 1.93
Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology (2012) 1.92
Racial disparities in the management of hospitalized patients with cirrhosis and complications of portal hypertension: a national study. Hepatology (2007) 1.82
Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf (2011) 1.76
Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology (2012) 1.74
Veterans Health Administration inpatient and outpatient care data: an overview. Eff Clin Pract (2002) 1.64
Intensive care of the patient with cirrhosis. Hepatology (2011) 1.54
Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J Gastroenterol Hepatol (2013) 1.33
Pharmacy data in the VA health care system. Med Care Res Rev (2003) 1.31
Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology (2000) 1.24
Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol (2009) 1.21
beta-Blockers protect against spontaneous bacterial peritonitis in cirrhotic patients: a meta-analysis. Liver Int (2009) 1.17
Bacterial infections in end-stage liver disease: current challenges and future directions. Gut (2012) 1.00
Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther (2012) 0.99
Beta-blockers in cirrhosis: friend and foe? Hepatology (2010) 0.96
Clinical pharmacology of portal hypertension. Gastroenterol Clin North Am (2010) 0.92
Beta-blockers have no effect on outcomes in patients with cirrhosis and severe infections. Hepatology (2011) 0.87
Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study. Gastroenterol Res Pract (2011) 0.87
Association between non-steroidal anti-inflammatory drugs and keratinocyte carcinomas of the skin among participants in the Veterans Affairs Topical Tretinoin Chemoprevention Trial. Pharmacoepidemiol Drug Saf (2011) 0.82
Editorial: Beta-blockers and the prevention of decompensation in cirrhosis: worth the trouble. Am J Gastroenterol (2012) 0.76
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther (2014) 2.88
Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. N Engl J Med (1993) 2.75
Small intestinal neoplasms. J Clin Gastroenterol (2001) 2.19
Effects of angiotensin-converting enzyme inhibitors and digoxin on health outcomes of very old patients with heart failure. SAGE Study Group. Systematic Assessment of Geriatric drug use via Epidemiology. Arch Intern Med (2000) 1.75
Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients. J Clin Invest (1989) 1.59
Influence of facility characteristics on use of antipsychotic medications in nursing homes. Med Care (2000) 1.55
Quantitative estimations of the contribution of different bile acid pathways to total bile acid synthesis in the rat. Gastroenterology (1997) 1.54
Oxidative and nonoxidative benzodiazepines and the risk of femur fracture. The Systematic Assessment of Geriatric Drug Use Via Epidemiology Study Group. J Clin Psychopharmacol (2000) 1.52
Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors. Stroke (2001) 1.47
Evaluating the use of angiotensin-converting enzyme inhibitors for older nursing home residents with chronic heart failure. J Am Geriatr Soc (1998) 1.47
Tacrine use in nursing homes: implications for prescribing new cholinesterase inhibitors. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. Neurology (1999) 1.39
Regulation of cholesterol 7 alpha-hydroxylase mRNA and transcriptional activity by taurocholate and cholesterol in the chronic biliary diverted rat. J Biol Chem (1991) 1.28
PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther (2011) 1.22
Immunochemical evidence for induction of a common form of hepatic cytochrome P-450 in rats treated with pregnenolone-16 alpha-carbonitrile or other steroidal or non-steroidal agents. Mol Pharmacol (1982) 1.16
Predictors of mortality in patients with Alzheimer's disease living in nursing homes. J Neurol Neurosurg Psychiatry (1999) 1.13
Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group. Am Heart J (2000) 1.08
Failure of intravenous infusion of taurocholate to down-regulate cholesterol 7 alpha-hydroxylase in rats with biliary fistulas. Gastroenterology (1995) 1.08
Effect of triplicate prescription policy on benzodiazepine administration in nursing home residents. Pharmacotherapy (2001) 1.07
Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Aliment Pharmacol Ther (2010) 1.05
Coronary heart disease surveillance: field application of an epidemiologic algorithm. J Clin Epidemiol (2000) 1.01
Proton pump inhibitors are associated with a high rate of serious infections in veterans with decompensated cirrhosis. Aliment Pharmacol Ther (2012) 0.99
High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int (1996) 0.98
Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology (1993) 0.97
Hep G2 cells: a model for studies on regulation of human cholesterol 7alpha-hydroxylase at the molecular level. Am J Physiol (1996) 0.97
Hormonal regulation of cholesterol 7alpha-hydroxylase specific activity, mRNA levels, and transcriptional activity in vivo in the rat. J Lipid Res (1997) 0.94
Impact of the type and severity of dementia on hospitalization and survival of the elderly. The SAGE Study Group. Dement Geriatr Cogn Disord (1999) 0.94
Regulation of bile acid synthesis. Hepatology (1991) 0.94
Transcriptional regulation of cholesterol 7 alpha-hydroxylase mRNA by conjugated bile acids in primary cultures of rat hepatocytes. J Biol Chem (1993) 0.94
Impact of legislation on nursing home care in the United States: lessons for the United Kingdom. BMJ (1999) 0.93
Physical activity, physical fitness, and coronary heart disease risk factors. Med Sci Sports Exerc (1995) 0.92
Comorbidity and drug use in cognitively impaired elderly living in long-term care. Dement Geriatr Cogn Disord (1998) 0.92
Effects of a community-based intervention on physical activity: the Pawtucket Heart Health Program. Am J Public Health (1999) 0.91
Gender differences in the relation between comorbidity and mortality of patients with Alzheimer's disease. Systematic Assessment of Geriatric drug use via Epidemiology (SAGE) Study Group. Neurology (1999) 0.91
Transcriptional regulation of hepatic sterol 27-hydroxylase by bile acids. Am J Physiol (1996) 0.90
Possible effect of DRGs on the classification of stroke: implications for epidemiological surveillance. Stroke (2001) 0.89
Gender differences in the frequency and treatment of behavior problems in Parkinson's disease. SAGE Study Group. Systematic Assessment and Geriatric drug use via Epidemiology. Mov Disord (2000) 0.89
Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis. Am J Physiol Gastrointest Liver Physiol (2001) 0.88
Clinical correlates and drug treatment of residents with stroke in long-term care. Stroke (2001) 0.88
Plasma total homocysteine and hemodialysis access thrombosis: a prospective study. J Am Soc Nephrol (1999) 0.87
Simultaneous measurement of cholesterol 7 alpha-hydroxylase activity by reverse-phase high-performance liquid chromatography using both endogenous and exogenous [4-14C]cholesterol as substrate. Anal Biochem (1989) 0.87
Function and regulation of hydroxylases involved in the bile acid biosynthesis pathways. Semin Liver Dis (1992) 0.87
Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study. Atherosclerosis (1996) 0.85
Short stature and cardiovascular disease among men and women from two southeastern New England communities. Int J Epidemiol (1998) 0.85
The association between perceived risk and actual cardiovascular disease. Epidemiology (1995) 0.84
Disruption of sleep architecture in minimal hepatic encephalopathy and ghrelin secretion. Aliment Pharmacol Ther (2011) 0.83
Pharmacologic treatment of diabetes in long-term care. J Clin Epidemiol (2001) 0.83
Regulation of bile acid synthesis. IV. Interrelationship between cholesterol and bile acid biosynthesis pathways. J Lipid Res (1990) 0.83
Cholesterol 7 alpha-hydroxylase: evidence for transcriptional regulation by cholesterol or metabolic products of cholesterol in the rat. J Lipid Res (1993) 0.83
Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis (1996) 0.83
Effect of hydrophobic bile acids on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and mRNA levels in the rat. J Biol Chem (1991) 0.82
Modified-orientation log to assess hepatic encephalopathy. Aliment Pharmacol Ther (2012) 0.82
Effects of different bile salts on steady-state mRNA levels and transcriptional activity of cholesterol 7 alpha-hydroxylase. Hepatology (1994) 0.82
Nutrition and health practices of diabetic and nondiabetic men and women from two southeastern New England communities. Nutr Health (1995) 0.82
Bile acid synthesis. VI. Regulation of cholesterol 7 alpha-hydroxylase by taurocholate and mevalonate. J Lipid Res (1992) 0.81
Changing trends in antihypertensive therapy in two New England communities during the 1980s. Pharmacotherapy (1993) 0.81
Gender differences in the treatment of behavior problems in Alzheimer's disease. SAGE Study Group. Systemic Assessment of Geriatric drug use via Epidemiology. Neurology (2000) 0.81
The impact of legislation on psychotropic drug use in nursing homes: a cross-national perspective. J Am Geriatr Soc (2000) 0.80
Role of newly synthesized cholesterol or its metabolites on the regulation of bile acid biosynthesis after short-term biliary diversion in the rat. Hepatology (1993) 0.80
Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study. Atherosclerosis (1995) 0.80
Sex-specific trends in validated coronary heart disease rates in southeastern New England, 1980-1991. Am J Epidemiol (2000) 0.79
Prevalence and descriptors of aspirin use as an antiplatelet agent in two New England communities. Ann Pharmacother (1993) 0.78
Correlates of oral contraceptive use in two New England communities: 1981-1993. Pharmacotherapy (1997) 0.78
Cholesterol and bile acid metabolism in cultures of primary rat bile ductular epithelial cells. Hepatology (1990) 0.78
Sedentary lifestyle and risk of coronary heart disease in women. Med Sci Sports Exerc (1995) 0.78
Self-reported alcohol intake using two different question formats in southeastern New England. Int J Epidemiol (1996) 0.78
Bile salts in submicellar concentrations promote bidirectional cholesterol transfer (exchange) as a function of their hydrophobicity. J Lipid Res (1990) 0.78
Lack of efficacy of ketorolac tromethamine for analgesia on patients undergoing colonoscopy. Am J Gastroenterol (1993) 0.77
Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7 alpha-hydroxylase in rats with subtotal nephrectomy. Kidney Int (1994) 0.77
Studies of alteration of hepatic cholesterol metabolism in puromycin-induced nephrotic syndrome in rats. Kidney Int (1993) 0.77
Effects of intervention on compliance to referral and lifestyle recommendations given at cholesterol screening programs. Am J Prev Med (1995) 0.77
Effect of bile acid composition and manipulation of enterohepatic circulation on leptin gene regulation. Metabolism (1998) 0.77
Estrogen use among nursing home residents with a diagnosis of Parkinson's disease. Mov Disord (2000) 0.77
Statin use and infections in Veterans with cirrhosis. Aliment Pharmacol Ther (2013) 0.76
Adverse outcomes of underuse of beta-blockers in elderly patients. JAMA (1997) 0.75
Elderly patients, use of antidepressants, and hip fracture. Lancet (1998) 0.75
Short-term reproducibility of total homocysteine determinations in stable renal transplant recipients. Transplant Proc (1999) 0.75
Endoscopic treatment of biliary tract disease. Va Med (1986) 0.75
Predictors of future antihypertensive use in patients with mildly elevated blood pressure. Pharmacotherapy (1995) 0.75
Physiological responses to increased dietary cholesterol: the case of the egg man. Hepatology (1991) 0.75
Is cigarette smoking an effect modifier of the relation between antihypertensive therapy and blood lipids? Epidemiology (1997) 0.75
Alternative approach: a systematic review of non-pharmacological non-spastic and non-trigeminal pain management in multiple sclerosis. Eur J Phys Rehabil Med (2014) 0.75
Is drug use by the elderly with cognitive impairment influenced by type of dementia? Pharmacotherapy (1999) 0.75
Effects of ursodeoxycholic acid, analogues of ursodeoxycholic acid and combination of bile acids on bile acid synthesis in cultured rat hepatocytes. Biochim Biophys Acta (1987) 0.75
Receptor-mediated stimulation of taurocholate efflux from the rat hepatocyte and the ex vivo perfused rat liver. Eur J Pharmacol (1990) 0.75
Comparison of the effects of intravenously and orally administered esomeprazole on acid output in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2005) 0.75
Cardiovascular risk profiles of oral contraceptive users and nonusers: a population-based study. Prev Med (1995) 0.75
Is antidepressant use changing? Prevalence and clinical correlates in two New England communities. Pharmacotherapy (1995) 0.75
Endoscopic laser therapy for GI diseases. Va Med (1986) 0.75
Lecithin protects against plasma membrane disruption by bile salts. J Surg Res (1998) 0.75
The effect of physician office visits on CHD risk factor modification as part of a worksite cholesterol screening program. Prev Med (1999) 0.75
Metabolic fate and hepatocyte toxicity of reverse amide analogs of conjugated ursodeoxycholate in the rat. J Steroid Biochem Mol Biol (1998) 0.75
Long-term management of cirrhosis. Appropriate supportive care is both critical and difficult. Postgrad Med (2001) 0.75
Medical therapy of gallstones: state of the art. Va Med (1986) 0.75
Cholesterol enhances membrane-damaging properties of model bile by increasing the intervesicular-intermixed micellar concentration of hydrophobic bile salts. J Surg Res (1999) 0.75